Manufacturing / Biological Products, Except Diagnostic Substances
Moderna, Inc.
MRNA
$222.50
+$1.36 (+0.62%)
Price as of Nov 3, 2026 14:32 UTC
19 B
Market Cap (Large Cap)
35%
IV Rank
85.6%
Implied Volatility
Nov 04
Next Earnings
Technical Signals
as of Oct 30
Mixed
4 of 7
Trend
- Above 20-day average $210.47
- Above 50-day average $180.47
- Above 200-day average $103.11 · +115.0%
- Moving averages stacked 20 > 50 > 200
Momentum
- Golden cross (50/200) —
- Momentum cross (20/50) 95d ago
Volume
- Below-average volume 0.5x avg
Price & Trend
Daily candles with EMA 20, SMA 50. Drag to zoom.
Options Activity & Greeks
Implied volatility, flow, and dealer positioning from the options market.
Put/Call Ratio
1.08
Balanced
Implied Volatility
85.6%
1% percentile
IV vs Realized
Options cheap
30d HV 92.8%
Options Heat Map
Delta-risk grid for MRNA options across strikes and expirations. Hover any cell for full Greeks.
Loading option chain data...
Insider Trades
0 buys
22 sells
| Date | Insider | Title | Type | Shares | Value | Since Trade |
|---|---|---|---|---|---|---|
| Oct 15, 2026 | Hoge Stephen | Exercise | 76,452 | $0 | -6.6% | |
| Oct 15, 2026 | Hoge Stephen | Sell | 39,145 | $8,640,084 | +0.0% | |
| Oct 15, 2026 | Hoge Stephen | Exercise | 76,452 | $933,479 | +1708.6% | |
| Oct 14, 2026 | Hoge Stephen | Exercise | 76,453 | $0 | -2.4% | |
| Oct 14, 2026 | Hoge Stephen | Sell | 38,774 | $8,277,086 | +3.4% | |
| Oct 14, 2026 | Hoge Stephen | Exercise | 76,453 | $933,491 | +1708.6% | |
| Oct 14, 2026 | Hoge Stephen | Sell | 450 | $96,368 | +3.1% | |
| Oct 05, 2026 | Mock James M | Exercise | 1,454 | $0 | +8.7% | |
| Oct 05, 2026 | Mock James M | Exercise | 1,454 | $0 | +8.7% | |
| Oct 05, 2026 | Mock James M | Tax_withholding | 704 | $133,767 | +16.2% |
Politician Trades in MRNA
| Date | Politician | Party | Type | Amount | Since Buy |
|---|---|---|---|---|---|
| Sep 24, 2026 | Maria Elvira Salazar | R | Sale | $1K-$15K | — |
| Sep 11, 2026 | Ro Khanna | D | Purchase | $1K-$15K | +54.0% |
| Sep 04, 2026 | Ro Khanna | D | Purchase | $1K-$15K | +52.3% |
| Aug 24, 2026 | Ro Khanna | D | Purchase | $1K-$15K | +59.6% |
| Aug 19, 2026 | Maria Elvira Salazar | R | Purchase | $1K-$15K | +27.1% |
| Aug 19, 2026 | Maria Elvira Salazar | R | Sale | $1K-$15K | — |
| Aug 03, 2026 | Ro Khanna | D | Purchase | $1K-$15K | +302.1% |
| Apr 13, 2026 | Ro Khanna | D | Purchase | $1K-$15K | +337.5% |
| Apr 13, 2026 | Ro Khanna | D | Purchase | $1K-$15K | +337.5% |
| Aug 26, 2025 | Ro Khanna | D | Sale | $1K-$15K | — |
Earnings History
| Date | Quarter | EPS Est. | EPS Actual | Surprise | Result |
|---|---|---|---|---|---|
| Oct 29, 2026 | Q3 2026 | -$1.30 | |||
| Jul 31, 2026 | Q2 2026 | -$2.12 | |||
| Jul 30, 2026 | Q2 2026 | -$2.12 | |||
| Jun 30, 2026 | Q2 2026 | -$2.12 | -$1.97 | +7.3% | Beat |
| Mar 31, 2026 | Q1 2026 | -$4.04 | -$3.40 | +15.8% | Beat |
| Dec 31, 2025 | Q4 2025 | -$2.70 | -$2.11 | +21.7% | Beat |
| Sep 30, 2025 | Q3 2025 | -$2.15 | -$0.51 | +76.3% | Beat |
| Jun 30, 2025 | Q2 2025 | -$3.03 | -$2.13 | +29.6% | Beat |
Track MRNA with ThetaPal
Get insider trade alerts, AI portfolio analysis, and options roll recommendations for MRNA and your entire portfolio.